Protein design provides a rigorous test of our knowledge about proteins and allows the creation of novel enzymes for biotechnological applications. Whereas progress has been made in designing proteins that mimic native proteins structurally 1-3 , it is more difficult to design functional proteins [4] [5] [6] [7] [8] . In comparison to recent successes in designing non-metalloproteins 4, 6, 7, 9, 10 , it is even more challenging to rationally design metalloproteins that reproduce both the structure and function of native metalloenzymes 5, 8, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . This is because protein metal-binding sites are much more varied than non-metal-containing sites, in terms of different metal ion oxidation states, preferred geometry and metal ion ligand donor sets. Because of their variability, it has been difficult to predict metal-binding site properties in silico, as many of the parameters, such as force fields, are ill-defined. Therefore, the successful design of a structural and functional metalloprotein would greatly advance the field of protein design and our understanding of enzymes. Here we report a successful, rational design of a structural and functional model of a metalloprotein, nitric oxide reductase (NOR), by introducing three histidines and one glutamate, predicted as ligands in the active site of NOR, into the distal pocket of myoglobin. A crystal structure of the designed protein confirms that the minimized computer model contains a haem/non-haem Fe B centre that is remarkably similar to that in the crystal structure. This designed protein also exhibits NO reduction activity, and so models both the structure and function of NOR, offering insight that the active site glutamate is required for both iron binding and activity. These results show that structural and functional metalloproteins can be rationally designed in silico.
Protein design provides a rigorous test of our knowledge about proteins and allows the creation of novel enzymes for biotechnological applications. Whereas progress has been made in designing proteins that mimic native proteins structurally [1] [2] [3] , it is more difficult to design functional proteins [4] [5] [6] [7] [8] . In comparison to recent successes in designing non-metalloproteins 4, 6, 7, 9, 10 , it is even more challenging to rationally design metalloproteins that reproduce both the structure and function of native metalloenzymes 5, 8, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . This is because protein metal-binding sites are much more varied than non-metal-containing sites, in terms of different metal ion oxidation states, preferred geometry and metal ion ligand donor sets. Because of their variability, it has been difficult to predict metal-binding site properties in silico, as many of the parameters, such as force fields, are ill-defined. Therefore, the successful design of a structural and functional metalloprotein would greatly advance the field of protein design and our understanding of enzymes. Here we report a successful, rational design of a structural and functional model of a metalloprotein, nitric oxide reductase (NOR), by introducing three histidines and one glutamate, predicted as ligands in the active site of NOR, into the distal pocket of myoglobin. A crystal structure of the designed protein confirms that the minimized computer model contains a haem/non-haem Fe B centre that is remarkably similar to that in the crystal structure. This designed protein also exhibits NO reduction activity, and so models both the structure and function of NOR, offering insight that the active site glutamate is required for both iron binding and activity. These results show that structural and functional metalloproteins can be rationally designed in silico.
NOR is a metalloenzyme in the denitrification pathway of anaerobic bacteria that is responsible for the two-electron reduction of NO to N 2 O (ref. 21) . It is a key enzyme in the nitrogen cycle that is critical for all life. Furthermore, well-studied denitrification enzymes may provide structural and spectroscopic models for mammalian enzymes that produce and utilize NO in signal transduction pathways. Progress in understanding NOR has been hampered by difficulties in obtaining the enzyme in high yield and the lack of a three-dimensional structure. Peptide sequence alignments and structural threading have suggested that NORs are structurally homologous to subunit I of haem-copper oxidases (HCOs) 22 . All six His ligands to the active site of HCO (two to the low spin haem, one to the high spin haem, and three to Cu B ) are conserved in NOR at the same predicted positions in HCO. The major structural difference is the replacement of a copper-binding site (Cu B ) with a non-haem iron-binding site (Fe B ) in NOR 21, 23 . Additionally, several conserved glutamates (not found in HCOs), have been identified near the catalytic haem/non-haem Fe B site of NOR, and are predicted to have a role in iron binding and/or catalysis 24, 25 . Synthetic models of NOR have been reported 21, 26, 27 . Despite these progresses, computational design and three-dimensional (3D) structural confirmation of structural and functional models remain elusive, and it is often difficult to address long-range non-covalent interactions important for enzymatic functions using these models.
We chose to use sperm whale myoglobin (Mb) as a scaffold protein in which to engineer an active site with NO reduction activity because it is much easier to prepare and crystallize than both native proteins and synthetic models of NOR. Myoglobin and its mutants are also more amenable to biophysical characterization due to the presence of a single metal centre, free from interference by other chromophores. Although sperm whale Mb contains a haem centre, it lacks the Fe B centre and NO reduction activity of NOR.
To design an Fe B centre in sperm whale Mb, we examined its distal pocket for locations to introduce the putative non-haem metal-binding site, consisting of three histidines and one glutamate. The histidine residues were introduced first 14 , as crystal structures of HCOs containing three conserved histidines are readily available (for example, cytochrome c oxidase). Based on overlays of the minimized structure of sperm whale Mb and cytochrome c oxidase, the distal His 64 in sperm whale Mb was chosen as one of the histidines, while Leu 29 and Phe 43 were mutated to histidines, to produce a non-haem metal-binding site. The V68E mutation to sperm whale Mb was chosen on the basis of its proximity and angle to the haem and the three His. The minimized computer model of the resultant triple mutant (sperm whale Mb L29H, F43H, V68E), named Fe B Mb, is shown in Fig. 1a . The Fe B site (modelled as Zn(II)) is within bonding distance to Ne of all three His residues (2.13 Å to H29, 2.20 Å to H43 and 2.09 Å to H64) and both O atoms of E68 (2.11 Å and 1.96 Å ), indicating that the proposed mutations would support iron binding in myoglobin, forming an Fe B site. A comparison of the computer model overlaid with the crystal structure of native cytochrome c oxidase ( Supplementary Fig. 1a ) suggests structural similarity between the two centres.
To test designed Fe B Mb for iron binding, Fe 21 was titrated into deoxy (reduced haem iron) Fe B Mb that contains haem, but not any metal ions in the Fe B site. The Soret band of deoxy Fe B Mb shifted slightly from 433 nm to 434 nm with Fe 21 addition. Concurrently, the peak at 557 nm was split into two shallow bands at 550 nm and 572 nm ( Fig. 2A, a) . This observation provided evidence that Fe B Mb is capable of incorporating iron into its designed metal-binding site, an important step towards modelling the Fe B site of NOR. In contrast, titration of Fe 21 into either wild-type Mb ( Fig. 2A, b ) or a Mb derivative with the three His but no Glu (called Fe B Mb(2Glu), Fig. 2A , c) resulted in no changes to the ultraviolet-visible spectra, indicating that both the histidines and particularly the glutamate, are required for Fe 21 (2.11 Å ) . A weaker interaction between the non-haem iron and the other O atom of E68 at 3.28 Å is also present. The crystal structure presented here is consistent with the proposal that a glutamate in the active site of NOR helps stabilize iron binding to the Fe B site. In addition to structural roles, the glutamate, histidines and water in the active site may also provide the two protons required for NO reduction.
The overlay of the crystal structure of Fe(II)-Fe B Mb with the computer model (Fig. 1c ) is striking. Although His 43 does not overlay as well since it is located in a flexible loop, the other two His and Glu 68 overlay well with one another. Zn(II) in the model and Fe(II) in the Fe B site do not overlay exactly, but are in a similar position, 1.08 Å away from each other. Furthermore, the model did not predict the recruitment of a water molecule into the haem pocket, possibly because Zn(II) was used to model Fe(II), in the absence of Fe(II) parameters. Future development of Fe(II) parameters (not in a haem) will probably help resolve this issue. The haem in the computer model is puckered instead of planar, causing the iron to be pulled ,1 Å out of the haem plane. If out-of-plane distortion of the model is considered, the Fe B to haem iron distance is ,4.8 Å for both the model and crystal structure. Therefore, the distinct similarities between the crystal structure and computer model suggest that metalloprotein active sites can be rationally designed.
As the Fe B iron is only ,4.8 Å away from the haem iron, it is possible for spin-coupling to occur between the two irons, as is shown in native NOR 23, 28 . To find out if the designed Fe B Mb mimics this aspect of native NOR, we titrated different equivalents of Fe 21 into deoxy Fe B Mb and then added blue copper azurin as a redox partner. In the absence of non-haem Fe 21 high spin Fe(III) haem EPR signal centred at g < 6 was observed ( Supplementary Fig. 2 ), suggesting that azurin can serve as a redox partner of Fe B Mb and oxidize the Fe(II) haem to Fe(III) haem. Interestingly, the intensity of the high spin haem signal decreased with Fe 21 binding to the Fe B site of Fe B Mb, which suggests that Fe 21 , when oxidized by azurin, is spin-coupled to the Fe(III) haem, similar to that observed in native NOR. This conclusion is also supported by electrochemical redox potential determination, as the presence of iron in the Fe B site resulted in a dramatic (112 mV) increase of the haem reduction potential (from 2158 6 4 mV to 246 6 2 mV versus the normal hydrogen electrode, NHE; Supplementary Fig. 3 ).
To test its NO activity, deoxy Fe B Mb was reacted with excess NO (,17 equiv.) in the presence of Fe 21 and monitored by ultravioletvisible spectroscopy (Fig. 2B) . These conditions approximate one turnover as only two electrons are available for reaction, one from reduced haem iron and one from ferrous Fe B . Furthermore, the reduction of NO to N 2 O is highly thermodynamically favourable (E 0 9 5 11.2 V) 29 , such that many common water soluble reductants can reduce NO non-enzymatically. Studying NO activity under single turnover conditions precludes non-enzymatic NO reduction and allows the reaction to be easily followed by spectroscopy. The appearance of visible peaks at 546 nm and 582 nm about 1 s after NO addition indicate fast NO binding. However, the NO-bound protein is not stable, and a species with peaks at 408 nm, 550 nm and 577 nm forms immediately after NO binding and is stable with no other changes in the spectrum over the course of 20 min (Fig. 2B, a, red spectrum) . The Soret band at 408 nm is characteristic of Fe(III) haem and the visible peaks are characteristic of an NO-bound haem, similar to the NObound oxidized Fe(III) haem (met) form of Fe B Mb ( Supplementary  Fig. 4 , black spectrum). Therefore, it appears that NO addition to Fe(II)-Fe B Mb results in a single species, namely the met-NO form. In contrast, when the Fe B site of Fe B Mb is empty, NO addition results in NO binding with no additional changes in the ultraviolet-visible spectrum over 20 min (Fig. 2B, a, black spectrum) . Therefore, these observations provide evidence that Fe B Mb with an intact Fe B site can react with NO, whereas Fe B Mb with a vacant Fe B site binds, but does not react with, NO.
As further controls, deoxy wild-type Mb lacking an Fe B site, and an Fe B Mb derivative lacking the glutamate (Fe B Mb(2Glu)) were reacted with NO in the presence or absence of Fe 21 . After 20 min incubation with NO, the ultraviolet-visible spectra of both proteins in the presence of Fe 21 remains unchanged (Fig. 2B, b and c ), suggesting the lack of NO activity for both proteins. These results are not surprising, as Fe 21 binding studies ( Fig. 2A, b and c) indicate no evidence of iron binding for either protein. Therefore, the histidines and glutamate are important not only for iron binding, but also for NO reduction activity.
The product of NO reduction was identified by gas chromatography/ mass spectrometry (GC/MS) under single turnover conditions by monitoring N 2 O formation in the headspace of the solution. Because of the high solubility of N 2 O (,25 mM in water at room temperature), this method cannot be used to quantify the rates of NO reduction under 1-2 turnover conditions ( Supplementary Fig. 8 ). Typical MS of NO (molecular mass 30 Da) and N 2 O (44 Da) are shown in Supplementary  Fig. 6 . When Fe(II)-Fe B Mb was incubated with NO, N 2 O production was observed by the appearance of a second peak in the GC with a longer retention time than NO (Fig. 3a) . Although the amount of N 2 O formed by Fe(II)-Fe B Mb is low, it is consistently more than that produced by Fe 21 alone (without protein, Fig. 3b ) over multiple samples. After no additional changes were observed over a period of 1-2 h, 2 equiv. of dithionite was added at 6 h to reduce the haem and Fe B sites again, approximating a second turnover. Although considerable N 2 O was produced in both samples (dithionite can non-enzymatically reduce NO to N 2 O), Fe(II)-Fe B Mb produced ,2 times more N 2 O than the control sample without protein, as observed in the chromatogram of only the molecular mass 44 Da component, representing the main ion peak of N 2 O ( Supplementary Fig. 7 , bottom blue traces). As an additional control, wild-type Mb in the presence of Fe 21 was reacted with NO with no N 2 O formation observed (Fig. 3c) , indicating that non-specifically bound iron, if present, does not contribute to NO reduction activity. The yield of N 2 O production by Fe(II)-Fe B Mb was estimated to be ,30%. These results, together with ultraviolet-visible data (Fig. 2) , indicate that designed Fe B Mb is a functional model of NOR.
We have rationally and successfully designed a protein model that both structurally and functionally mimics native NOR. We have demonstrated that both the glutamate and histidine ligands, which are conserved in NOR, are essential for iron binding and NO reduction activity. Being much smaller, easier to express in high yields, and free of other chromophores, this designed protein will serve as an excellent model for mechanistic studies of NOR.
METHODS SUMMARY
Fe B Mb was purified from inclusion bodies by resolublization with 7 M GuHCl, reconstitution with a haem cyanide solution and dialysis against potassium phosphate, pH 7 (Methods). Protein mass was confirmed by SDS-PAGE and electrospray ionization mass spectrometry (ESI-MS). Ultraviolet visible spectra were collected at room temperature in buffered solution. EPR spectra were recorded as a glass at 4 K. Protein reduction potentials were measured by a spectroelectrochemical method as described previously 30 . Fe(II)-bound Fe B Mb crystals were grown anaerobically by the hanging drop method in an inert atmosphere glove box at room temperature. To test NO reduction activity, a solution of Fe B Mb was de-oxygenated and transferred to a glove box where it was reduced with dithionite. Excess reductant was removed with a size exclusion column (PD-10). FeCl 2 was added to reconstitute the Fe B site. NO gas (,17 equiv.) was added to the resulting Fe(II)-Fe B Mb protein and allowed to react with stirring (anaerobically). N 2 O production was monitored via GC/MS.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
METHODS
Fe B Mb computer modelling. A computer model of the designed protein Fe B Mb was constructed with the L29H, F43H and V68E mutations to the crystal structure of sperm whale Mb (PDB: 1JP6) using the modelling extension in VMD (Visual Molecular Dynamics) 31 . Rendering was also performed in VMD. H43 was rotated about Ca to ensure interaction with the haem pocket as opposed to the bulk solvent.
To assess the ability of the designed Fe B site to bind an iron ion, molecular dynamics simulations were performed. To mimic an iron ion, the water molecule found in the crystal structure of the distal pocket of sperm whale Mb was changed to a Zn(II) ion. The resulting computer model was then minimized with NAMD (Molecular Dynamics Simulator) 32 using 5,000 minimization steps at 0 K, then 10,000 molecular dynamics steps (1 fs per step) via an NVT ensemble (where the number of particles N, the volume V, and the temperature T of the system are kept constant) at 310 K. Construction, expression and purification of Fe B Mb. The triple mutant L29H/ F43H/H64/V68E of sperm whale myoglobin (called Fe B Mb) was constructed using a protocol described previously 14, 33 The resulting cloudy red solution was stirred for ,1 h after the final addition and centrifuged for 30 min at 8,000g to remove precipitate. The supernatant (500 ml) was dialysed against 8 l of H 2 O and 4 l of 100 mM (ionic strength) potassium phosphate at pH 7 to remove excess GuHCl. The protein was refolded with three additional buffer changes with at least 6 h between changes. The protein was then centrifuged for 30 min at 8,000g and concentrated with a stirred cell concentrator (8000 MWCO membrane; Millipore) to 10 ml. The concentrated protein was then loaded onto a gel filtration column (Sephacryl S-100 High Resolution; GE Healthcare) equilibrated with 100 mM potassium phosphate pH 7 and eluted with the same buffer. The fractions with a high ($4.5) R/Z ratio (defined as an absorption ratio of A 406nm /A 280nm ; the higher the R/Z ratio, the more pure the protein is) were pooled, concentrated, and dialysed twice against 100 mM potassium phosphate pH 7 containing 30 mM EDTA, then twice with 100 mM potassium phosphate pH 7 treated with a chelating resin (Chelex 100, iminodiacetic acid, Sigma) containing 100 mM NaCl, and finally three times with 100 mM potassium phosphate pH 7 treated with chelating resin to remove adventitious metal. Fig. 2 ). After 5 min, the sample was then transferred into an EPR tube and flash frozen in liquid N 2 . EPR samples contained 0.5 mM Fe B Mb, 1.5 mM azurin and 6.8% glycerol in 50 mM Bis-Tris (bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane), pH 7.0. Control experiments of wild-type sperm whale Mb only, Fe B Mb(2Glu) only and Fe 21 only were prepared under identical conditions. Spectra were recorded at 4 K on a Bruker ESP 300 equipped with an Oxford liquid helium cryostat and an ITC4 temperature controller. Spectroelectrochemical determination of reduction potential. Protein reduction potentials were measured using an optically transparent thin layer electrode (OTTLE) as previously described 30, 34 , with the following changes. A 200 mM protein solution, ,0.6 ml, containing 2 molar equivalents of Fe 21 when required, and 100 mM NaCl in 50 mM Bis-Tris pH 7 buffer or 100 mM potassium phosphate pH 7 buffer without added NaCl were used. Each protein solution also contained 80 mM each of phenazine methosulphate (PMS, Sigma) and anthraquinone-2sulphonate (AQS, Sigma) as electron transfer mediators. For the spectroelectrochemistry study of deoxy Fe B Mb in the presence of Fe 21 (starting from the reduced deoxy metal bound form and transitioning to the oxidized met form), the protein was reduced in the glove box first with dithionite and purified of excess dithionite before mediator (AQS only) and Fe 21 addition, and subsequent transfer to the degassed OTTLE cell. The headspace of the OTTLE cell was purged with N 2 during the experiment to prevent O 2 contamination. The potential of the working electrode was applied in the negative direction for deoxy Fe B Mb and in the positive direction for deoxy Fe B Mb 1 Fe 21 . The ultraviolet-visible spectrum of the protein at each potential was recorded with a Cary 3E or Cary 5000 spectrophotometer until no further spectral changes were observed. Data analysis. The spectra from 300-800 nm were analysed by global analysis using singular value decomposition (SVD) and non-linear regression modelling software (SpecFit/32, Spectrum Software Associates). The reduction potential of each protein solution was obtained by fitting the data to the best fit model, an A « B model, in SpecFit/32 and checked by generating a Nernst plot at a single wavelength 30 . The Ag/AgCl (3 M KCl) reduction potentials were converted to NHE potentials by adding 0.209 V. Since the reduction potentials obtained from the Nernst plots and from SpecFit/32 modelling were generally within 616 mV of each other, only the potentials derived from SpecFit/32 were reported ( Supplementary Fig. 3 ).
Purification of NO and NO saturated solution preparation. NO gas (Matheson Trigas, 99%) was purged of N 2 O 3 , NO 2 and higher N x O y impurities by passing it through a bubbler containing 1 M NaOH and a second bubbler of water before it entered a reaction vessel filled with ultrapure water 35 . The reaction solution was first purged with helium to remove O 2 to make a ,1.1 mM saturated NO solution, as measured by spectroscopic titrations of a saturated solution of NO to oxy WT Mb to form met WT Mb. NO was added via a gas-tight syringe to a protein and/or metal solution. X-ray crystallographic studies. Fe 21 incorporated Fe B Mb was prepared as above. Fe B Mb crystals were grown anaerobically in a glove box at room temperature. Red crystals were observed after 2-3 days. Diffractable crystals were obtained from a 1.5 mM protein solution in 20 mM potassium phosphate pH 7 mixed 1:1 with well buffer (0.2 M sodium acetate trihydrate, 0.1 M sodium cacodylate trihydrate pH 6.5 and 30% w/v PEG 8000). The well of the crystal tray was filled with 300 ml of the same solution. Fe(II)-Fe B Mb crystals were soaked in a cryoprotectant solution and flash frozen in liquid N 2 in a glove box before data collection. Data collection. Diffraction data of Fe(II)-Fe B Mb were collected using Fe-edge absorption (1.7309 Å ) as wavelengths of data collection at the Brookhaven National Synchrotron Light Source X12C beamline. All data were integrated using the program HKL2000 (ref. 36) . Crystal structure determination. The crystal structure was solved by the molecular replacement method using MOLREP in the CCP4 Package 37 . Refinement was performed using X-plor 38 and SHELX'97 (ref. 39 ). The position of Fe 21 in the Fe B site, and the E68 and H43 residues were rebuilt by the program O 40 . NO activity studies by GC/MS. NO reduction was monitored by GC/MS using an HP-Plot Q column (Aligent), installed in a Hewlett Packard 5890 gas chromatography system equipped with an online mass spectrometer (Micromass 70-VSE). As dithionite can reduce NO non-enzymatically, the NO activity of Fe B Mb was probed under one turnover conditions whereby the two electrons required for reduction, one from the reduced Fe(II) haem and one from the ferrous Fe B site of Fe(II)-Fe B Mb, were rate limiting. Where applicable, an extra 2 molar equivalents of dithionite was added to the protein/metal solution to induce an additional turnover. Glucose, glucose oxidase and catalase were added to scavenge residual O 2 as described 41 . Under anaerobic conditions, a 2.67 ml reaction sample consisting of 0.6 mM protein, 10 mM glucose, glucose oxidase (100 mg ml 21 ) and catalase (50 mg ml 21 ) in 20 mM Bis-Tris (treated with chelating agent) pH 7 was prepared in a Schlenk flask fitted with a septum. The head-space of the flask was then exchanged to helium. Purified NO gas (1 atm) was injected into the head space of the reaction flask via a gas-tight syringe and the reaction mixture was stirred at room temperature (the molar ratio of NO:protein < 17:1). Typically, 250 ml of head space gas was analysed via GC/MS at different time intervals to observe NO and N 2 O levels. MS of NO (molecular mass 30 Da) and N 2 O (molecular mass 44 Da) are shown in Supplementary Fig. 6 . NO 2 (molecular mass 46 Da) formation was not observed. 
